Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
Merck & Co. and German contract research organization ElexoPharm will work together to develop novel drug candidates targeting aldosterone synthase for the treatment of cardiovascular disease. ElexoPharm scores $1.9 million up front and could receive another $40 million in milestones throughout the course of the pact. ElexoPharm was spun out of Saarland University’s department of pharmaceutical and medicinal chemistry in 2005.
This article has been sent to the following recipient: